Stem Cell Therapy Market Size, Growth, Trends and Forecast 2026–2035
According to Rohan Patil, who specializes in biotechnology, regenerative medicine, and healthcare market research, with 5+ years of experience in market research and industry analysis, the stem cell therapy market is on track for strong long-term expansion, growing from USD 768.72 million in 2026 to USD 5,835.53 million by 2035 at a 25.26% CAGR. His research identifies allogeneic stem cell therapies and oncology applications as the leading market segments, while autologous therapies and musculoskeletal disorders present significant future opportunities. He highlights North America's market leadership, rapid growth across Asia-Pacific, and competitive developments led by companies including Abeona Therapeutics, Alloy Therapeutics, Astellas Pharma, Bluebird Bio, Caribou Biosciences, Novo Nordisk, and Takeda Pharmaceuticals Co. Ltd.
Last Updated : 01 July 2026
Category: Therapeutic Area
Insight Code: 5451
Format: PDF / PPT / Excel